0:00Hey, guys. Welcome to the podcast, and welcome my new friend, Lauren Dwyer. Hey, Lauren. Welcome. Hi. Glad to be here. Yeah. Thanks for having me. Awesome. I'm excited. And new friend because Lauren and I literally just met. Like, I like to give you guys the backstory, and we we literally just met via LinkedIn because I did a post asking people if they knew about Blue Sky, and she had responded and and gave me a really good kind of explanation of what it was.
0:31And and I was like, alright. Let me reach out, and here we are. And we're gonna talk about Blue Sky today. So, but before we get to that, this episode is sponsored by Medical Watch, our friends at Medical Watch. I'm a big fan. I don't know if you guys have checked them out yet, but you definitely need to go to medical.watch sign up. It's free to sign up. And, basically, Medical Watch will help you understand what your HCPs are saying about your
1:01products and diseases on social media. And they are now they now added Blue Sky as one of their platforms. So you absolutely have to check it out. And so, Lauren, why don't we jump into because I'm I'm not a big Twitter x Blue Sky kind of person. So I'm gonna rely on you. Like, what is Blue Sky, and what can you tell us about? So Blue Sky is it's it's another social media platform.
1:35It actually did you know, I was looking it up, but it actually was developed by people that were at Twitter initially, in 2019. And, eventually, it's it became a separate company and a corporation. The person who was leading the project at Twitter ended up, you know, becoming the CEO. But, really, the perspective was to have a platform very similar to Twitter or X where you can share, you know, short bits of information and updates or or links to stuff and have, you
2:08know, a conversation, but also have it be more in a decentralized manner. So the users have a little bit more control over their algorithms and then also potentially how their data is used. So I think that was the inception, and then it eventually became its own company. Cool. Awesome. Now are would you say are there, like, marked differences in in Blue Sky versus Twitter?
2:38Mhmm. Like, when you first glance at the platforms, they're they're very similar. The way you look at it, the feed, it is it's similar. I think there is, like, a slight differences with Twitter. You can or X, you can share, like, two two hundred eighty characters. And if you pay, you can share more characters. Like, if you are, like, an influencer and stuff, you can share longer posts and stuff. With Blue Sky, I think it's, 280 you're limited to.
3:09You have a feed. It looks very similar. There are, like, no ads on on Blue Sky at this time, so you don't have those in your feed, which is different than than Twitter. There, you can moderate, you know, some of the content or what you block or mute. I think that was, you know, some issues with some of the changes with x too is that there are, you know, sometimes more bots or, you know, spam of ads and stuff. So but generally, when you first, like, glance at the platforms, they're very similar.
3:41I think the capability is if you're more of, like, an influencer or really sharing a lot of education on a regular basis, you may notice, like, there's you can't video stream or audio stream like you could on X, but you and you can't share as many photos or or other things too. But there is generally speaking, they look very similar. Got you. Yeah. And a lot of people commented on my LinkedIn post saying that it's it's it's like the the early days of Twitter Mhmm.
4:15Which they seem a lot of people seem to like. It's going back to kind of Twitter before it it evolved into x and what it is now with the ads and all this other stuff. So a lot of people that are, like, avid legacy Twitter people seem to be migrating to Blue Sky. Do you think that's accurate? I do think that there are certain communities where yeah. Like, if they have like, specifically, like, the therapeutic area, like, I work with
4:48nephrologists, and they have a very active community on on they they had enough Twitter, enough x, and then now they have enough Blue Sky. But, you know, it's an engaged community. And so if they're used to that and they don't wanna necessarily deal with some of the advertisements and some of the bots or the you know, some of these, like, getting odd messages, DMs, and stuff, it's it's you know, they don't have that. And if the community does transition altogether, I think you do get that sense of,
5:23like, you can still, post stuff, get, you know, real time feedback, get, you know, that engagement. I think that really has driven, you know, some of the medical community online, which is, you know, why why I, you know, have that interest too. So I think it feels like a little bit more grassroots. It's some of the early adopters who are really there to use it and and to engage. Right. So, but broadly speaking, it's it's a much smaller, platform too than than x now.
5:54Well, the other thing kinda, like, that I noticed in my research is that there there seems to be a lot of people out there, and I'm gonna say MSLs because that's kind of the audience I've been talking to, that just don't seem to know what it is. So I'm curious, like, why do you think people aren't aware of it? I I think people aren't aware because it is, like, a newer platform. Like I said, it it did you know, it was developed in 2019. And then it was slowly built out where it was, like, invitation only for a long time.
6:29And then in '20 like, within 2024, they did open it up to the public. So it's not something where it's been around a long time. There were a limited amount of users previously. And so and now being open to the public, you they've seen the growth increase a lot in the past year. And that's probably why, you know, even if you are, you know, up to date with the digital community, you may just not know because it is a newer platform. Right. Yeah. Which is probably why it got on the radar for, like, Medical Watch and why they're doing their
7:03social monitoring because it's starting to get more and more popular. Mhmm. But, you know, getting back to MSLs, like, why would they why should they even, you know, be aware of or or be concerned with or have interest in another social platform? For I think for a couple of reasons, you would want to is just because I think the reason that you would even monitor any platform, generally speaking, if if you have a certain therapeutic
7:36area that you have an interest in, is just that there is it's it's how information is being shared. It's where people are going to get answers to questions. And I think from a, if you work in the, you know, medical affairs and separate company is to get that real time insights about, like, what you know, your therapeutic area, what's changing, because everything does change very quickly. And and sometimes getting that information can be really slow, but if you can go to a platform
8:07like Blue Sky or X, you know, you can see what people are saying and also what questions people have still and make sure you're, I think, addressing those questions if if, you know, you have a new a therapy and stuff and people don't understand, you know, specific specific things about it, I think you can really understand, like, what what about our messaging isn't resonating with them and stuff. So but it is it's a place where people are going and engaging and I think also learning. And so overlooking it, you know, historically, people would go to journals and and share
8:40publications or at congresses and stuff. And it's and these days, just having information at your fingertips in this platform and also, like, having a broader community than just, like, what they're historically used to, you know, within, like, an institution. At Grand Rounds, they can really connect with people geographically from all over and globally too to kinda get answers to their questions and and stay up to date with information. Got you. Alright. So just to unpack that a little bit.
9:10So, obviously, it's import and I've done episodes on this before on social listening and Yeah. The importance of social media. So, obviously, it's important for MSLs to be monitoring social media to see Yeah. What is going on out there. And different social channels are going to have different audiences is what you're so so some some KOLs may adopt x, and that might be their platform of choice. And then some KOLs may migrate to Blue Sky, and that might be their platform of choice.
9:48And that's where they're engaging and posting information. Is that accurate? Yeah. I would say that it's it's really understanding where who's on which platform and also I think also where they're engaging. Because I think that's the purpose of, you know, doing the social listening on different channels and and getting, you know, just where is that engagement happening and how is that community, like, sharing information. So it is for some communities that may be on X still, maybe they haven't switched over, and
10:21then there's some that they may be very active on Blue Sky. And then there may be communities that that are in both places. So having that awareness that, you know, where is information, but also the engagement. Because I think it's not just the posts that are shared, but it's also, like, how people are responding to that too. Right. Yep. And would you say can you I don't know if you can tell at this point because I think right now, it's, like, a lot of early adopters. Okay. But could you tell, is the content different? Is what people are share what people are sharing on Blue Sky, do you feel that it
10:55differs in any way than what you might see on other platforms? I I think it's very similar to how people would use X. I Okay. I think they it is just a different space for them to share it on a platform that maybe they have a preference for versus, like, I think the difference for content that you would share on LinkedIn versus, you know, X or Blue Sky. So I really see it as, like, for some people, more of an alternative to how they would use,
11:29like and share information very similarly to X. So I I see the engagement being very similar. If you look at your feeds, you know, it it it it is very similar. So I think that's why it's very comfortable for certain people, like early adopters and people who were engaged on x to transition because it it's just simple and easy. And they can also cross post too if they do wanna maintain, you know, their toe, you know, and their their pool of engagers on x as well.
11:59So they can cross post between both platforms as well. And would you say that Blue Sky might wind up taking over as a preferred platform for medical conversations moving forward or in the future versus an axe? And the reason I say that is, like, don't I have a crystal ball, but and I'm sure you don't either. But, like, it looking at x and how commercialized it's become and how much fluff there is, do you think that maybe medical conversations may be more may migrate more to a
12:36platform like Blue Sky? I I think, ultimately, I think the what's hard is the user base of x is very large. And from what I understand too is much more global than Blue Sky, I think Blue Sky is a great place for if you have that sense of community to if it the engagement is high, it can replace for certain aspects and stuff.
13:08However, it is much a much smaller community, so it does have to continue to grow. I think if people really want to have if if clinicians really want to have that level of influence. So I don't know if I envision it necessarily replacing X. If people continue to stay engaged and continue to use it regularly, I think it has the potential. I see I see all different therapeutic areas there. I see journals. I see societies there.
13:39So they are sharing information there. But I do think, you know, from what I've read is that the engagement on Blue Sky is a 5% of the user base, and it is a much smaller user base. And then Twitter, I think it's it's, you know, it's 37,000,000 on Blue Sky compared with 600 on on twit on X. And so and 40% of the users on X are engaging more regularly. So I think, you know, it has the potential, but they really have to you know, it has to be the
14:14the community that's there and using and engaging it. So there is potentially potential or it's it's like certain specific communities will find it as their preferred platform. So I don't think broadly, it will replace x. Yeah. And I'm and again, I'm I'm I know that these are the questions that I have for myself just being curious about what this is, what it's for, why it's different, and and, you know, is it gonna take off?
14:45Or in a year from now, is there gonna be no blue sky because it didn't, like, you know, it didn't take hold? And I think that that's what a lot of people that are listening are probably thinking as well. The other thing is, do you think and this is I'm just this is by a personal question of, like, do you think that blue sky kinda came about or started to become more popular at for political reasons because of people that no longer support Elon Musk or, you know, anti
15:20Trumpers or whatever. And now I don't actually, now Trump and Musk don't even like each other. So, like, maybe people go back. So, like, do you think there's a political Yes. Yes. I think that there that's definitely when I think some of the the adoption of Blue Sky did, you know, increases towards the 2024. I I think that sometimes to the medical community, they had, you know, I think, in
15:55their mind, very rigorous standards for how they share information and they, you know, share evidence and stuff. And I think, you know, with the rise the way we get information is completely changed, obviously, with social media and stuff versus and then they're used to journalistic standards. And so I think there is a bit of, like, disenchantment from the medical community with just how, like, medical information is shared on their minds. So, yes, I think, generally speaking, they have migrated because of political reasons and then
16:26also because I think the way they view, like, this acceptance sometimes of, you know, how medical information is shared in this day and age versus, like, how traditionally it was done, you know, with trials and, you know, I think a level of rigor that they, you know, maybe don't see sometimes in in the evolution of social media too and and how information is shared. So I think there is definitely, you know, they feel a little bit more the lens on the medical
16:58community is a little bit more critical too than it has been in the past. So it's it's a place where they they're going and sharing information, and they feel that they don't have to deal with maybe some of the other potential misinformation that could be shared on social media. Interesting. Interesting. So let's talk about I'd love to talk a little bit about the how. Mhmm. Like, how should MSLs be listening and monitoring their KOLs and their HCPs on a
17:29platform like Blue Sky? Mhmm. You know, I think it depends on you know? Well, it's easy to get a Blue Sky profile. You it's really linked to, an email address. You can you can build one, and you can go then on the website and follow. There are you know, I mentioned there's different communities, and so there's starter packs that make it easy also to go and monitor on on BlueSide because you can I think they you
18:00can put a 100 different users in a starter pack? And then so in nephrology, they have nephrology starter pack. And then emergency medicine has emergency medicine starter pack. There's even, like, women in medicine starter packs and stuff. And and so that may include journals. It may include different users. It may include societies or even institutions. So it's easy to go, you know, create your profile, follow all of those, and and kind of build your list of people that you wanna follow.
18:31I know also there are, like, other tools. Large organizations often have, like, social media media monitoring because then it is, like, a more comprehensive way to just keep track of what people are seeing on different channels like we've talked about because the communities may get kind of split up. So but it is easy individually to, you know, create the profile, build your own community, and an algorithm to, like, follow the different, places by finding these starter
19:02packs. And they have a feed where you can kind of select two different starter packs that you may wanna follow as well. Awesome. Yeah. And I know and this is a loaded question, and I I know that it's gonna vary from company to company, but I'm curious to hear. Do you feel MSLs should be engaging on on social platforms like a blue sky, engaging with KOLs and interacting? I it's totally up to the obviously, you have to adhere to your company's social media policy.
19:36We have, like, one where I work, you know, and it's this SOP very clearly outlining kind of if you do have a profile, like, how you have to identify yourself and and how you can engage. So that really should be kind of your, guidance for how you do engage. I think it can be a way for you to, you know, get information. You can reference it sometimes when you have conversations. Like, I saw, you know, you you mentioned this.
20:07It may be easier because because everything you post online is, you know, it's it's a paper trail. It's an information. So you wanna be very clear about how you're posting and verse as an individual versus, like, a representative of your organization too. Yeah. Well, there's this there we're we're getting into this digital evolution where it you know, we're we're starting to see some companies are are starting to get a little more and I don't
20:37know if the word's risky or aggressive, but, they're they're starting to do more on the social digital AI side of the equation Mhmm. Because they don't wanna get left behind. They wanna be on the forefront, but you gotta be careful because you don't you also don't wanna become a a compliance risk. Mhmm. So where do you see digital platforms, social media platforms, in how they shape the future
21:08for medical affairs? I know it's a that's a very broad question, but I'm curious to see where does this go? I think it is it's it's really interesting because, like you said, like, how will Blue Sky you know, where where will we see it in a year from now? Will it be kind of the same number of users but very highly engaged? You know, I think you really have to think about where people go for information, and they
21:39may be going to both places. And so do you need to have a presence on both places, not necessarily to engage, but make sure that information is there. You know, some companies may choose to have a a handle on x, and then also Blue Sky because they see their users in both places, and they just wanna make sure they have access to, like, data that was recently shared and updated information, not necessarily to interact with the audience, but the audience could interact with the data you shared and how you present it
22:11and stuff. So I think it's it's, you know, keeping a pulse on who's engaging on social media and how they are doing it is important to to stay up to date and understanding kind of the best ways to to update them on data and information about, you know, your therapies or the therapeutic space that you're in. Because I think, really, the benefits of social media are the engagement, you know, behind it and and how the communities are built and why they're going there, you know, for for that
22:46information and that real time information. Yeah. You know, so one of the debates and one of the conversations that I've had recently with certain so there's a lot of there's a lot of old school MSLs out there, OGs, that are out there and they're doing their thing. And, you know, this is really new to them. They're and and as much as there are are a lot of MSLs that are socially savvy, they're digitally savvy, they're adopting AI, and they're incorporating this into their day to
23:16day. There's a lot of people out there that they may not know the first thing about this, or there may be some reluctance, maybe because they just don't they're not that familiar with it. Do you feel like do they get left behind? Like, is this a mandatory? Do they need to like, is your what is your message to MSLs that haven't fully adopted the social aspect, social media aspect to their job?
23:48I I don't know if they necessarily get left behind, but I think it is a very helpful tool, like, in your tool belt to have and to rely on, and it's easy to get and access. It doesn't like, I think it's also very helpful to understand, I think, a network of, you know, the network in the therapeutic space. You can learn a little bit more about why, you know, this person references, you know, how
24:19this this clinician does things because actually they're connected on, you know, blue sky and they often communicate. You know? I think it really helps build this understanding of, you know, the network and the level, like, the the sphere of influence. And so I would say that you don't have to do it, but I think it's something that is very easy to do that, you know, you shouldn't overlook. You know? And there are ways to do it. You know, if you don't wanna monitor it yourself, you could use tools to do it for you and to keep you up to date, or your company could consider, you know, using tools to kinda
24:53keep you in the know. I think a lot of, you know, opinion leader analytic, you know, platforms too have started incorporating more social media as well. And kind of how they you you can get information about, you know, the the space as well and who really is influential and who's who's leading, you know, that sharing the information and where people go to get that information. So I think it's something that I wouldn't overlook because I think it can really inform,
25:24you know, how you engage with the space too. Yeah. And you mentioned tools. I just I think that what we're talking about right now has gotten a lot easier because of the tools. Like, the functionality that's built into CRM systems now and all of these other platforms that exist. And, again, you know, check out Medical Watch because it does this. It it does social monitoring for you, and it will do it on Blue Sky. And I mentioned that because we technology is just moving at such a fast pace.
25:59So as much as I and I'm trying to keep up. And I know when I talk to MSLs, they're all trying to keep up. So I think there's there's this I think there's it's important to embrace it and try and and give it a you know, just give it give it some time in your day. You have to schedule some time in your day to educate yourself and to put some effort into this because it doesn't just happen automatically. So when in in your role at Travere Mhmm.
26:35Like, do you see this as and for other companies, do you see this as a training need? Do companies need to start to say, okay. We need to make sure that we're incorporating individualized training well, team training, but looking at the individual needs of these MSLs to make sure that we're giving them the education that they need to stay, ahead of the curve or at least keep up with it. I I think it is valuable because there are, you know, there's incredibly experienced MSLs that
27:10are very you know, they know how to, you know, engage and and share information. But, you know, if they don't do the social media listening and monitoring, I think it's it's a disservice. So and I think their effectiveness, you know, it's you'll they'll see that a little bit of it can keep them as effective as they, you know, have traditionally been. So I do see it as, like, a way to, just just keep people, like, informed about, like, the
27:43benefits of this is an easy thing to do. This can inform you. It can give you, better information about, like, maybe where or how, you know, you share information and who you are engaging with, you know, because I do think like I said, it's it's there are people that are really, you know, influential because they are highly engaged on social media, and they also know how to communicate information. And so we can also learn from them because I think that's a huge part of what makes medical
28:14affairs effective is if you communicate well. And that's something they do very well on social media because you have to do it succinctly and clearly. So I think it's definitely a tool that and and an area that should not be overlooked within, you know, training or a best practice sharing, you know, within a team. Yeah. Mhmm. Alright. So last question. Let's talk AI for a second. Does AI replace the MSL? Oh.
28:46Controversy. I don't think completely because I truly think benefits of very effective MSLs are relationships and and having that in person connection. I do think that there are aspects of the MSL role that, you know, have been incredibly time consuming that will be, you know, made incredibly more efficient. And so, hopefully you know, I don't think AI replaces the MSL, but MSLs who use AI will
29:21definitely be much more effective in their roles long term, and they'll probably replace MSLs that don't embrace, like, new technology, and and leveraging it. I think that's, like, a perfect way to kinda wrap this up. I think it's important, guys, to embrace technology and to give it a try and to and to put time on your calendar to do this. Because if you don't, days are gonna turn into weeks, weeks are gonna turn into months, and then you're gonna be like, oh, I really wish I did the social listening thing, or I wish I
29:52learned more about AI, or I wish I you know, whatever. So I would encourage everybody to to really kinda dive into this even if it's slowly because I think that there's huge benefits to it. But, Lauren, you're awesome. Thank you. Thank you for having me. Yeah. This is a great conversation. It was super I think it was super eye opening too because I just I love to learn about new stuff, and I hope you guys got a lot out of it. If you did, please share it with others. As always, I really do appreciate your support of this show, and we'll see you next time.